Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added to the history and the previous revision v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:55:23.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page removed the government funding status notice. This change does not affect the study data, status, or records displayed on the page.
    Difference
    0.4%
    Check dated 2025-11-17T20:04:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new Study Status entry (version 61) was added on 2025-11-04 reflecting status updates from 2025-11-02, and an earlier entry from 2025-10-06 was removed.
    Difference
    0.2%
    Check dated 2025-11-10T17:23:52.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The new screenshot shows updated entries in the Record History, with multiple updates to Study Status and Contacts/Locations for NCT04603807. These updates indicate ongoing maintenance of recruitment status and trial details.
    Difference
    0.1%
    Check dated 2025-11-03T13:47:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added a new date and a new 'Study Status Contacts/Locations' section (as of 2025-10-03), and removed an older date (2025-09-08).
    Difference
    0.9%
    Check dated 2025-10-13T05:40:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    9%
    Check dated 2025-10-06T04:23:54.000Z thumbnail image

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.